PLRXPliant Therapeutics, Inc.

$82M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42M-26.7% YoY

Gross Profit

$42M100.0% margin

Operating Income

-$42M-99.6% margin

Net Income

-$42M-99.3% margin

EPS (Diluted)

$-1.17

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$39M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$296M

Total Liabilities

$12M

Stockholders' Equity

$283M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$57M	-26.7%
Gross Profit	$42M	$57M	-26.7%
Operating Income	-$42M	-$1M	-3283.0%
Net Income	-$42M	-$631,000	-6482.1%

PLRX FY 2020 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena